Cancer Biopsy Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Instruments, Kits And Consumables, Services), By Type (Tissue Biopsies, Liquid), By Application, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Type
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Cancer Biopsy Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. Cancer Biopsy Market: Product Business Analysis
                    4.1. Product Market Share, 2024 & 2033
                    4.2. Product Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Instruments
                        4.4.1. Instruments Market, 2021 - 2033 (USD Million)
                    4.5. Kits and Consumables
                        4.5.1. Kits and Consumables Market, 2021 - 2033 (USD Million)
                    4.6. Services
                        4.6.1. Services Market, 2021 - 2033 (USD Million)
Chapter 5. Cancer Biopsy Market: Type Business Analysis
                    5.1. Type Market Share, 2024 & 2033
                    5.2. Type Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    5.4. Tissue Biopsies
                        5.4.1. Tissue Biopsies Market, 2021 - 2033 (USD Million)
                            5.4.1.1. Needle Biopsies
                                5.4.1.1.1. Needle Biopsies Market, 2021 - 2033 (USD Million)
                            5.4.1.2. Surgical Biopsies
                                5.4.1.2.1. Surgical Biopsies Market, 2021 - 2033 (USD Million)
                    5.5. Liquid Biopsies
                        5.5.1. Liquid Biopsies Market, 2021 - 2033 (USD Million)
                            5.5.1.1. Fine Needle Aspiration (FNA)
                                5.5.1.1.1. Fine Needle Aspiration (FNA) Market, 2021 - 2033 (USD Million)
                            5.5.1.2. Core Needle Biopsy (CNB)
                                5.5.1.2.1. Core Needle Biopsy (CNB) Market, 2021 - 2033 (USD Million)
                    5.6. Others
Chapter 6. Cancer Biopsy Market: Application Business Analysis
                    6.1. Application Market Share, 2024 & 2033
                    6.2. Application Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    6.4. Breast Cancer
                        6.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Colorectal Cancer
                        6.5.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Cervical Cancers
                        6.6.1. Cervical Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Lung Cancers
                        6.7.1. Lung Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.8. Prostate Cancers
                        6.8.1. Prostate Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.9. Skin Cancers
                        6.9.1. Skin Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.10. Blood Cancers
                        6.10.1. Blood Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.11. Kidney Cancers
                        6.11.1. Kidney Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.12. Liver Cancers
                        6.12.1. Liver Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.13. Pancreatic Cancers
                        6.13.1. Pancreatic Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.14. Ovarian Cancers
                        6.14.1. Ovarian Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.15. Others
                        6.15.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Cancer Biopsy Market: Regional Estimates & Trend Analysis
                    7.1. Regional Market Share Analysis, 2024 & 2033
                    7.2. Regional Market Dashboard
                    7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    7.4. North America
                        7.4.1. North America Cancer Biopsy Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
                        7.4.2. U.S.
                            7.4.2.1. Key Country Dynamics
                            7.4.2.2. U.S. Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.4.3. Canada
                            7.4.3.1. Key Country Dynamics
                            7.4.3.2. Canada Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.4.4. Mexico
                            7.4.4.1. Key Country Dynamics
                            7.4.4.2. Mexico Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.5. Europe
                        7.5.1. Europe Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.2. UK
                            7.5.2.1. Key Country Dynamics
                            7.5.2.2. UK Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.3. Germany
                            7.5.3.1. Key Country Dynamics
                            7.5.3.2. Germany Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.4. France
                            7.5.4.1. Key Country Dynamics
                            7.5.4.2. France Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.5. Italy
                            7.5.5.1. Key Country Dynamics
                            7.5.5.2. Italy Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.6. Spain
                            7.5.6.1. Key Country Dynamics
                            7.5.6.2. Spain Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.7. Denmark
                            7.5.7.1. Key Country Dynamics
                            7.5.7.2. Denmark Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.8. Sweden
                            7.5.8.1. Key Country Dynamics
                            7.5.8.2. Sweden Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.5.9. Norway
                            7.5.9.1. Key Country Dynamics
                            7.5.9.2. Norway Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.6. Asia Pacific
                        7.6.1. Asia Pacific Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.2. Japan
                            7.6.2.1. Key Country Dynamics
                            7.6.2.2. Japan Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.3. China
                            7.6.3.1. Key Country Dynamics
                            7.6.3.2. China Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.4. India
                            7.6.4.1. Key Country Dynamics
                            7.6.4.2. India Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.5. Australia
                            7.6.5.1. Key Country Dynamics
                            7.6.5.2. Australia Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.6. South Korea
                            7.6.6.1. Key Country Dynamics
                            7.6.6.2. South Korea Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.6.7. Thailand
                            7.6.7.1. Key Country Dynamics
                            7.6.7.2. Thailand Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.7. Latin America
                        7.7.1. Latin America Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.7.2. Brazil
                            7.7.2.1. Key Country Dynamics
                            7.7.2.2. Japan Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.7.3. Argentina
                            7.7.3.1. Key Country Dynamics
                            7.7.3.2. China Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.8. Middle East and Africa
                        7.8.1. Middle East and Africa Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.8.2. South Africa
                            7.8.2.1. Key Country Dynamics
                            7.8.2.2. South Africa Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.8.3. Saudi Arabia
                            7.8.3.1. Key Country Dynamics
                            7.8.3.2. Saudi Arabia Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.8.4. UAE
                            7.8.4.1. Key Country Dynamics
                            7.8.4.2. UAE Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.8.5. Kuwait
                            7.8.5.1. Key Country Dynamics
                            7.8.5.2. Kuwait Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Participant Overview
                    8.2. Company Market Position Analysis
                    8.3. Company Categorization
                    8.4. Strategy Mapping
                    8.5. Company Profiles/Listing
                        8.5.1. QIAGEN
                            8.5.1.1. Overview
                            8.5.1.2. Financial Performance
                            8.5.1.3. Product Benchmarking
                            8.5.1.4. Strategic Initiatives
                        8.5.2. Illumina, Inc.
                            8.5.2.1. Overview
                            8.5.2.2. Financial Performance
                            8.5.2.3. Product Benchmarking
                            8.5.2.4. Strategic Initiatives
                        8.5.3. ANGLE plc
                            8.5.3.1. Overview
                            8.5.3.2. Financial Performance
                            8.5.3.3. Product Benchmarking
                            8.5.3.4. Strategic Initiatives
                        8.5.4. BD (Becton, Dickinson and Company)
                            8.5.4.1. Overview
                            8.5.4.2. Financial Performance
                            8.5.4.3. Product Benchmarking
                            8.5.4.4. Strategic Initiatives
                        8.5.5. Myriad Genetics, Inc.
                            8.5.5.1. Overview
                            8.5.5.2. Financial Performance
                            8.5.5.3. Product Benchmarking
                            8.5.5.4. Strategic Initiatives
                        8.5.6. Hologic, Inc.
                            8.5.6.1. Overview
                            8.5.6.2. Financial Performance
                            8.5.6.3. Product Benchmarking
                            8.5.6.4. Strategic Initiatives
                        8.5.7. Biocept, Inc.
                            8.5.7.1. Overview
                            8.5.7.2. Financial Performance
                            8.5.7.3. Product Benchmarking
                            8.5.7.4. Strategic Initiatives
                        8.5.8. Thermo Fisher Scientific, Inc.
                            8.5.8.1. Overview
                            8.5.8.2. Financial Performance
                            8.5.8.3. Product Benchmarking
                            8.5.8.4. Strategic Initiatives
                        8.5.9. Danaher
                            8.5.9.1. Overview
                            8.5.9.2. Financial Performance
                            8.5.9.3. Product Benchmarking
                            8.5.9.4. Strategic Initiatives
                        8.5.10. F. Hoffmann-La Roche Ltd.
                            8.5.10.1. Overview
                            8.5.10.2. Financial Performance
                            8.5.10.3. Product Benchmarking
                            8.5.10.4. Strategic Initiatives
                        8.5.11. Lucence Health Inc.
                            8.5.11.1. Overview
                            8.5.11.2. Financial Performance
                            8.5.11.3. Product Benchmarking
                            8.5.11.4. Strategic Initiatives
                        8.5.12. GRAIL, Inc.
                            8.5.12.1. Overview
                            8.5.12.2. Financial Performance
                            8.5.12.3. Product Benchmarking
                            8.5.12.4. Strategic Initiatives
                        8.5.13. Guardant Health Inc.
                            8.5.13.1. Overview
                            8.5.13.2. Financial Performance
                            8.5.13.3. Product Benchmarking
                            8.5.13.4. Strategic Initiatives
                        8.5.14. Exact Sciences Corporation
                            8.5.14.1. Overview
                            8.5.14.2. Financial Performance
                            8.5.14.3. Product Benchmarking
                            8.5.14.4. Strategic Initiatives
                        8.5.15. Freenome Holdings, Inc.
                            8.5.15.1. Overview
                            8.5.15.2. Financial Performance
                            8.5.15.3. Product Benchmarking
                            8.5.15.4. Strategic Initiatives
                        8.5.16. Biodesix (Integrated Diagnostics)
                            8.5.16.1. Overview
                            8.5.16.2. Financial Performance
                            8.5.16.3. Product Benchmarking
                            8.5.16.4. Strategic Initiatives
                        8.5.17. Oncimmune
                            8.5.17.1. Overview
                            8.5.17.2. Financial Performance
                            8.5.17.3. Product Benchmarking
                            8.5.17.4. Strategic Initiatives
                        8.5.18. Epigenomics AG
                            8.5.18.1. Overview
                            8.5.18.2. Financial Performance
                            8.5.18.3. Product Benchmarking
                            8.5.18.4. Strategic Initiatives
                        8.5.19. HelioHealth (Laboratory for Advanced Medicine)
                            8.5.19.1. Overview
                            8.5.19.2. Financial Performance
                            8.5.19.3. Product Benchmarking
                            8.5.19.4. Strategic Initiatives
                        8.5.20. Genesystems, Inc. (Genesys Biolabs)
                            8.5.20.1. Overview
                            8.5.20.2. Financial Performance
                            8.5.20.3. Product Benchmarking
                            8.5.20.4. Strategic Initiatives
                        8.5.21. Chronix Biomedical, Inc.
                            8.5.21.1. Overview
                            8.5.21.2. Financial Performance
                            8.5.21.3. Product Benchmarking
                            8.5.21.4. Strategic Initiatives
                        8.5.22. Personal Genome Diagnostics Inc.
                            8.5.22.1. Overview
                            8.5.22.2. Financial Performance
                            8.5.22.3. Product Benchmarking
                            8.5.22.4. Strategic Initiatives
                        8.5.23. Natera, Inc.
                            8.5.23.1. Overview
                            8.5.23.2. Financial Performance
                            8.5.23.3. Product Benchmarking
                            8.5.23.4. Strategic Initiatives
                        8.5.24. Personalis Inc.
                            8.5.24.1. Overview
                            8.5.24.2. Financial Performance
                            8.5.24.3. Product Benchmarking
                            8.5.24.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Cancer Biopsy Market, by region, 2021 - 2033 (USD Million)
Table 4. Global Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 5. Global Cancer Biopsy Market, by distribution channel, 2021 - 2033 (USD Million)
Table 6. North America Cancer Biopsy Market, by country, 2021 - 2033 (USD Million)
Table 7. North America Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 8. North America Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 9. North America Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 10. U.S. Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 11. U.S. Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 12. U.S. Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 13. Canada Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 14. Canada Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 15. Canada Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 16. Mexico Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 17. Mexico Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 18. Mexico Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 19. Europe Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 20. Europe Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 21. Europe Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 22. Europe Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 23. UK Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 24. UK Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 25. UK Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 26. Germany Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 27. Germany Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 28. Germany Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 29. France Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 30. France Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 31. France Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 32. Italy Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 33. Italy Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 34. Italy Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 35. Spain Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 36. Spain Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 37. Spain Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 38. Norway Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 39. Norway Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 40. Norway Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 41. Denmark Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 42. Denmark Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 43. Denmark Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 44. Sweden Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 45. Sweden Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 46. Sweden Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 47. Asia Pacific Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 48. Asia Pacific Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 49. Asia Pacific Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 50. Asia Pacific Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 51. Japan Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 52. Japan Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 53. Japan Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 54. China Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 55. China Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 56. China Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 57. India Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 58. India Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 59. India Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 60. Australia Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 61. Australia Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 62. Australia Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 63. South Korea Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 64. South Korea Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 65. South Korea Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 66. Thailand Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 67. Thailand Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 68. Thailand Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 69. Latin America Cancer Biopsy Market, by country, 2021 - 2033 (USD Million)
Table 70. Latin America Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 71. Latin America Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 72. Latin America Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 73. Brazil Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 74. Brazil Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 75. Brazil Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 76. Argentina Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 77. Argentina Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 78. Argentina Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 79. Middle East & Africa Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 80. Middle East & Africa Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 81. Middle East & Africa Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 82. Middle East & Africa Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 83. South Africa Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 84. South Africa Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 85. South Africa Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 86. Saudi Arabia Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 87. Saudi Arabia Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 88. Saudi Arabia Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 89. UAE Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 90. UAE Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 91. UAE Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 92. Kuwait Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 93. Kuwait Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 94. Kuwait Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Cancer Biopsy Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and Product outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Cancer Biopsy Market dynamics
Fig. 12 Cancer Biopsy Market: Porter’s five forces analysis
Fig. 13 Cancer Biopsy Market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Instruments market, 2021 - 2033 (USD Million)
Fig. 16 Kits and Consumables market, 2021 - 2033 (USD Million)
Fig. 17 Services market, 2021 - 2033 (USD Million)
Fig. 18 Type market, 2021 - 2033 (USD Million)
Fig. 19 Tissue Biopsies market, 2021 - 2033 (USD Million)
Fig. 20 Liquid Biopsies market, 2021 - 2033 (USD Million)
Fig. 21 Others market, 2021 - 2033 (USD Million)
Fig. 22 Application market, 2021 - 2033 (USD Million)
Fig. 23 Breast Cancer market, 2021 - 2033 (USD Million)
Fig. 24 Colorectal Cancer market, 2021 - 2033 (USD Million)
Fig. 25 Cervical Cancer market, 2021 - 2033 (USD Million)
Fig. 26 Lung Cancer market, 2021 - 2033 (USD Million)
Fig. 27 Prostate Cancer market, 2021 - 2033 (USD Million)
Fig. 28 Skin Cancer market, 2021 - 2033 (USD Million)
Fig. 29 Blood Cancer market, 2021 - 2033 (USD Million)
Fig. 30 Kidney Cancer market, 2021 - 2033 (USD Million)
Fig. 31 Liver Cancer market, 2021 - 2033 (USD Million)
Fig. 32 Pancreatic Cancer market, 2021 - 2033 (USD Million)
Fig. 33 Ovarian Cancer market, 2021 - 2033 (USD Million)
Fig. 34 Others market, 2021 - 2033 (USD Million)
Fig. 35 Cancer Biopsy Market revenue, by region
Fig. 36 Regional marketplace: Key takeaways
Fig. 37 North America Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 38 U.S. country dynamics
Fig. 39 U.S. Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 40 Canada country dynamics
Fig. 41 Canada Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 42 Mexico country dynamics
Fig. 43 Mexico Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 44 Europe Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 45 UK country dynamics
Fig. 46 UK Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 47 Germany country dynamics
Fig. 48 Germany Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 49 France country dynamics
Fig. 50 France Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 51 Italy country dynamics
Fig. 52 Italy Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 53 Spain country dynamics
Fig. 54 Spain Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 55 Norway country dynamics
Fig. 56 Norway Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 57 Sweden country dynamics
Fig. 58 Sweden Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 59 Denmark country dynamics
Fig. 60 Denmark Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 61 Asia Pacific Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 62 Japan country dynamics
Fig. 63 Japan Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 64 China country dynamics
Fig. 65 China Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 66 India country dynamics
Fig. 67 India Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 68 Australia country dynamics
Fig. 69 Australia Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 70 South Korea country dynamics
Fig. 71 South Korea Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 72 Thailand country dynamics
Fig. 73 Thailand Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 74 Latin America Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 75 Brazil country dynamics
Fig. 76 Brazil Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 77 Argentina country dynamics
Fig. 78 Argentina Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 79 MEA Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 80 South Africa country dynamics
Fig. 81 South Africa Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 82 Saudi Arabia country dynamics
Fig. 83 Saudi Arabia Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 84 UAE country dynamics
Fig. 85 UAE Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 86 Kuwait country dynamics
Fig. 87 Kuwait Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 88 Company categorization
Fig. 89 Company market position analysis
Fig. 90 Strategic framework